Article Details

AzurRx BioPharma, Inc. (NASDAQ:AZRX) Files An 8-K Entry into a Material Definitive Agreement

Retrieved on: 2021-03-10 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

AzurRx BioPharma, Inc. (NASDAQ:AZRX) Files An 8-K Entry into a Material Definitive Agreement. View article details on hiswai:

Excerpt

Item 1.01 Entry into a Definitive Material Agreement. The Offering. On March 7, 2021, AzurRx BioPharma, Inc. (the “Company”) entered into a securities ...

Article found on: marketexclusive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up